Bright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202

April 19, 2023

https://www.globenewswire.com/news-release/2023/04/19/2649845/0/en/Bright-Minds-Biosciences-Receives-a-Favorable-Written-Opinion-from-the-International-Searching-Authority-for-BMB-202.html

— BMB-202 is a highly selective 5-HT2A agonist that exhibits a more than 30-fold selectivity over 5-HT2C and more than 500-fold selectivity over 5-HT2B —

Read more at globenewswire.com

Related news for (DRUG)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.